News
VVOS
1.710
+1.18%
0.020
Weekly Report: what happened at VVOS last week (0202-0206)?
Weekly Report · 1d ago
Vivos Therapeutics Appoints Gregg Johnson to Board
TipRanks · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna 
Reuters · 5d ago
BUZZ-Vivos jumps as device maker partners with SoundHealth to broaden sleep, allergy offerings
Reuters · 5d ago
Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology
TipRanks · 5d ago
Vivos Therapeutics signs 12-part media series with New to the Street
TipRanks · 5d ago
Vivos Therapeutics And SoundHealth Collaborate To Advance Access To SoundHealth's Consumer-Focused Airway And Sleep Health Technologies
Benzinga · 5d ago
Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies
Reuters · 5d ago
VIVOS THERAPEUTICS AND SOUNDHEALTH ANNOUNCE COLLABORATION TO EXPAND ACCESS TO SOUNDHEALTH’S GROUNDBREAKING FDA-CLEARED ALLERGY AND SLEEP TECHNOLOGIES
Reuters · 5d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 02/03 21:05
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
Benzinga · 02/03 11:23
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 02/02 21:05
Weekly Report: what happened at VVOS last week (0126-0130)?
Weekly Report · 02/02 09:00
Weekly Report: what happened at VVOS last week (0119-0123)?
Weekly Report · 01/26 09:00
Vivos Therapeutics Completes Warrant Inducement Financing Transaction
TipRanks · 01/20 21:36
Vivos Therapeutics Raises $4.6 Million Through Warrant Exercise at Reduced Price
Reuters · 01/20 21:07
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
Barchart · 01/20 16:31
Weekly Report: what happened at VVOS last week (0112-0116)?
Weekly Report · 01/19 09:00
More
Webull provides a variety of real-time VVOS stock news. You can receive the latest news about Vivos Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About VVOS
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.